Immunic, Inc.
Pharmaceutical company · New York, United States · Nasdaq: IMUX
Immunic, Inc. is a pharmaceutical company headquartered in New York, United States. Its shares trade on Nasdaq under the ticker IMUX. It has reported private securities offerings to the US SEC, most recently $200 million sold in a notice filed in 2026.
Immunic at a glance
What does Immunic do?
Private fundraising reported to the SEC
24 Form D notices; the most recent reported $200 million sold (2026).
Frequently asked questions about Immunic
Where is Immunic headquartered?
Immunic, Inc. is headquartered in New York, United States.
What does Immunic do?
Immunic, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Immunic a public company?
Yes. Immunic, Inc. trades on Nasdaq under the ticker IMUX.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- SELLAS Life Sciences Group, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.